| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 08/02/2001 | WO2001005389A3 N-sulfonylaminiacid derivatives as inhibitors of metalloprteinase |
| 08/02/2001 | US20010011136 Anticancer agents |
| 08/02/2001 | US20010011135 Anticancer agents |
| 08/01/2001 | EP1120423A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | EP1120422A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | EP1119542A1 Prostaglandin receptor ligands |
| 08/01/2001 | EP1119529A2 Chemical constructs |
| 08/01/2001 | EP0877737B1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 08/01/2001 | EP0693514B1 Amides and ethers of perfluoropolyoxyalkylene sulphonic- or perfluoropolyoxyalkylene carboxylic acids and a method of obtaining the same |
| 08/01/2001 | CN1306526A Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
| 08/01/2001 | CN1306509A Substituted benzamides, their prodn. and use as cysteine protease inhibitors |
| 07/31/2001 | US6268532 Sulfonated perfluorovinyl functional monomers |
| 07/31/2001 | US6268507 Hydantoin derivatives |
| 07/31/2001 | US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis. |
| 07/31/2001 | CA2333231A1 Process for producing sulfonylimide compound |
| 07/31/2001 | CA2322099A1 Process for producing sulfonylimide compound |
| 07/26/2001 | WO1999015129A3 SELECTIVE cPLA2 INHIBITORS |
| 07/25/2001 | EP1117409A2 Use of benzenesulfonyl(thio)ureas for the treatment of dysfunctions of the autonomous nervous system |
| 07/25/2001 | EP0889876B1 Meta-substituted phenylene sulphonamide derivatives |
| 07/25/2001 | CN1305466A Substituted phenyl pyridazinones |
| 07/25/2001 | CN1305463A Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 07/25/2001 | CN1068872C Method for preparing 2-trifluoromethoxy benzene sulphonamide |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265445 Cardiovascular disorders |
| 07/24/2001 | US6265399 Alkylation; cyclization |
| 07/24/2001 | CA2085465C Thrombin inhibitors based on the amino acid sequence of hirudin |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | WO2001051463A1 Glyburide composition |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051456A2 Antibacterial agents |
| 07/19/2001 | WO2001042226A8 Nitro-sulfobenzamides |
| 07/19/2001 | US20010008736 Sulfonylimide compounds |
| 07/19/2001 | CA2397575A1 Antibacterial agents |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/18/2001 | EP1116713A1 Novel color-developing compound and recording material |
| 07/18/2001 | EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds |
| 07/18/2001 | EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 07/18/2001 | EP1115716A1 2-phenylpyran-4-one derivatives |
| 07/18/2001 | EP1115701A1 Arylsulfonanilide ureas |
| 07/18/2001 | EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 07/18/2001 | EP1115393A1 Sulfonamide derivatives |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | EP0721446B1 Chiral surfactants and methods for their use in chiral separations |
| 07/18/2001 | CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily |
| 07/18/2001 | CN1304402A Sulfonamide derivatives |
| 07/18/2001 | CN1304401A Calcilytic compounds |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/18/2001 | CN1068587C Ortho-substituted benzoic acid derivatives |
| 07/18/2001 | CN1068586C Crystalline polymorphic form of (S.S.S)-N-(1-[2-carboxy-3-(N2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl) throsine |
| 07/17/2001 | US6262305 Process and intermediates for preparing 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazole compounds |
| 07/17/2001 | US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 07/12/2001 | WO2001049721A2 Bacterial genes and proteins that are essential for cell viability and their uses |
| 07/12/2001 | WO2001049657A1 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 07/12/2001 | WO2001027096A9 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 07/12/2001 | DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 07/12/2001 | CA2396040A1 Novel bacterial genes and proteins that are essential for cell viability and their uses |
| 07/11/2001 | EP1114815A2 Process to prepare taxol |
| 07/11/2001 | EP1114035A1 Quinazoline derivatives and pharmaceutical applications thereof |
| 07/11/2001 | EP1114024A1 Urokinase inhibitors |
| 07/11/2001 | CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same |
| 07/10/2001 | US6258850 3-aryl-2-hydroxypropionic acid derivative (I) |
| 07/10/2001 | US6258822 Urokinase inhibitors |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258360 Benzoate conjugates; antitumor agents |
| 07/05/2001 | WO2001047875A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 07/05/2001 | WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| 07/05/2001 | WO2001047873A1 Method for producing n-substituted 2,4-diamino-5-fluoro benzonitriles and novel intermediates |
| 07/05/2001 | WO2001047872A1 Method for preparing fluorosulfonyl imide monomer |
| 07/05/2001 | WO2001047868A1 Novel phenylalanine derivatives |
| 07/05/2001 | WO2001047866A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | CA2395716A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 07/05/2001 | CA2394098A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2389977A1 Method for preparing fluorosulfonyl imide monomer |
| 07/04/2001 | EP1113000A1 Benzene derivatives and medicinal use thereof |
| 07/04/2001 | EP0883617B1 Herbicidal sulfonamide derivatives |
| 07/03/2001 | US6255496 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
| 07/03/2001 | US6255326 Antiinflammatory agent; autoimmune diseases |
| 07/03/2001 | US6254797 Ionic conducting material having good anticorrosive properties |
| 06/28/2001 | WO2001046130A1 Process for the preparation of diphenyl ether compounds |
| 06/28/2001 | WO2001046125A2 Cd45 inhibitors |
| 06/28/2001 | WO2001046124A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 06/28/2001 | WO2001046120A1 Improved preparation of 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines |
| 06/28/2001 | WO2001045694A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | DE19962932A1 Production of N-substituted 2,4-diamino-5-fluoro-benzonitrile derivatives, useful as herbicide intermediates, involves multi-stage process from 2-bromo-4-fluoro-aniline via known and new intermediates |
| 06/28/2001 | DE19960204A1 Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Norlbornylamino substituted derivatives, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 06/28/2001 | CA2394603A1 Urotensin-ii receptor antagonists |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP1109544A1 Potassium channel inhibitors and method |
| 06/27/2001 | EP1109542A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 06/27/2001 | CN1067678C Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound |
| 06/26/2001 | US6252111 Method for producing sulfonimide or its salt |
| 06/26/2001 | US6252104 3,6-disubstituted-2-oxynaphthalene derivatives; raw materials for synthesis of such materials as dyes, pigments, photosensitive materials |
| 06/26/2001 | US6252096 Tetrafluoroazidoaniline and method of making and using the same |
| 06/26/2001 | US6252070 Reacting aryl bromide with butyllithium and zinc bromide to give aryl zinc bromide; reacting with corresponding benzothiazine compound |